JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Royston, D.
Right arrow Articles by Jochum, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Royston, D.
Right arrow Articles by Jochum, M.
Related Collections
Right arrow Blood
Right arrow Surgery
Right arrow Heart
Anesth Analg 2001;92:830-836
© 2001 International Anesthesia Research Society

CARDIOVASCULAR ANESTHESIA

Is Perioperative Plasma Aprotinin Concentration More Predictable and Constant After a Weight-Related Dose Regimen?

David Royston, FRCA*, Rebecca Cardigan, PhD{dagger}, Cornelia Gippner-Steppert, PhD{ddagger}, and Marianne Jochum, PhD{ddagger}

*Department of Anaesthesia, Harefield Hospital, Harefield, Middlesex, United Kingdom; {dagger}Department of Haematology, University College London Medical School, London, England, United Kingdom; and {ddagger}Division of Clinical Biochemistry in the Department of Surgery, Klinikum Innenstadt der LM-Universität München, Munich, Germany

Address correspondence and reprint requests to Dr. Dave Royston, Department of Anaesthesia, Harefield Hospital, Harefield, Middlesex, UB9 6JH, UK. Address e-mail to Dave{at}tharg.demon.co.uk

To determine whether a weight-related dose had advantages over a fixed, large-dose regimen, we measured plasma concentrations of aprotinin by using an enzyme-linked immunosorbent assay method at set time points in 30 patients having heart surgery with cardiopulmonary bypass. A weight-related dose comprising a preincision bolus injection of 40,000 kallikrein-inhibiting units (KIU)/kg (5.6 mg/kg) with the same amount given in the oxygenator prime was compared with a large-dose regimen of 2 x 106 KIU (280 mg) preincision bolus and addition to prime, together with an infusion of 500,000 KIU/h (70 mg/h). Peak plasma concentration in the Weight-Related group was less variable than with the fixed-dose regimen. Forty percent of patients allocated to the fixed-dose regimen had an aprotinin concentration of more than 400 KIU/mL, compared with none in the Weight-Related group; this suggests a relative overdosing in the early surgical period in the Fixed-Dose group. There was great individual variability between patients in the time-concentration curves for aprotinin, with no difference between the two regimens. The weight-related dose regimen benefited by not requiring an intraoperative infusion while achieving the same plasma concentrations of aprotinin.

Implications: Peak plasma concentrations of aprotinin were less variable with a weight-related dose schedule. This has implications for safety with regard to control of anticoagulation and cost in patients with small body mass. Plasma concentrations varied greatly with time between patients. This observation has implications for determining an optimal dose on the basis of aprotinin’s currently known mechanisms of action.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
M. D. McEvoy, M. J. Sabbagh, A. G. Taylor, J. A. Zavadzkas, C. N. Koval, R. E. Stroud, R. L. Ford, J. E. McLean, S. T. Reeves, R. Mukherjee, et al.
Aprotinin Modifies Left Ventricular Contractility and Cytokine Release After Ischemia-Reperfusion in a Dose-Dependent Manner in a Murine Model
Anesth. Analg., February 1, 2009; 108(2): 399 - 406.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. A. Olenchock Jr, P. H.U. Lee, T. Yehoshua, S. A. Murphy, J. Symes, and G. Tolis Jr
Impact of Aprotinin on Adverse Clinical Outcomes and Mortality up to 12 Years in a Registry of 3,337 Patients
Ann. Thorac. Surg., August 1, 2008; 86(2): 560 - 567.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. D. McEvoy, A.-G. Taylor, J. A. Zavadzkas, I. M. Mains, R. L. Ford, R. E. Stroud, L. B. Jeffords, C. U. Beck, S. T. Reeves, and F. G. Spinale
Aprotinin Exerts Differential and Dose-Dependent Effects on Myocardial Contractility, Oxidative Stress, and Cytokine Release After Ischemia-Reperfusion
Ann. Thorac. Surg., August 1, 2008; 86(2): 568 - 575.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. D. McEvoy, S. T. Reeves, J. G. Reves, and F. G. Spinale
Aprotinin in Cardiac Surgery: A Review of Conventional and Novel Mechanisms of Action
Anesth. Analg., October 1, 2007; 105(4): 949 - 962.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
W. Dietrich, R. Busley, and M. Kriner
High-Dose Aprotinin in Cardiac Surgery: Is High-Dose High Enough?: An Analysis of 8281 Cardiac Surgical Patients Treated with Aprotinin
Anesth. Analg., November 1, 2006; 103(5): 1074 - 1081.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
A. Kokoszka, P. Kuflik, F. Bitan, A. Casden, and M. Neuwirth
Evidence-Based Review of the Role of Aprotinin in Blood Conservation During Orthopaedic Surgery
J. Bone Joint Surg. Am., May 1, 2005; 87(5): 1129 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. Koster, S. Huebler, F. Merkle, T. Hentschel, M. Grundel, T. Krabatsch, L. Tambeur, M. Praus, H. Habazettl, W. M. Kuebler, et al.
Heparin-Level-Based Anticoagulation Management During Cardiopulmonary Bypass: A Pilot Investigation on the Effects of a Half-Dose Aprotinin Protocol on Postoperative Blood Loss and Hemostatic Activation and Inflammatory Response
Anesth. Analg., February 1, 2004; 98(2): 285 - 290.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
H. Mossinger, W. Dietrich, S. L. Braun, M. Jochum, H. Meisner, and J. A. Richter
High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery
Ann. Thorac. Surg., February 1, 2003; 75(2): 430 - 437.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
G. A. Nuttall, D. N. Fass, L. J. Oyen, W. C. Oliver Jr., and M. H. Ereth
A Study of a Weight-Adjusted Aprotinin Dosing Schedule During Cardiac Surgery
Anesth. Analg., February 1, 2002; 94(2): 283 - 289.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.